Ecolab Inc.

(New York Stock Exchange)
Somewhat Bearish -35

Ecolab (ECL) Stock After Recent Run Looks Pricey Versus Cash Flow And Earnings Models - simplywall.st

πŸ“‰ Ecolab (ECL) recently closed at US$276.29, marking a 2.7% gain over the past week and 9.1% over the last month.

πŸ’° The company's latest twelve-month Free Cash Flow is approximately $2.0 billion with projections reaching $2.47 billion by 2028.

πŸ“Š A Discounted Cash Flow (DCF) model estimates an intrinsic value of US$207.51 per share, implying the stock is trading 33.1% above fair value.

πŸ” Ecolab currently trades at a P/E ratio of 36.93x, significantly higher than its peer group average of 23.26x and a proprietary fair ratio of 24.70x.

⚠️ The article identifies a valuation score of 0 out of 6, indicating the stock looks pricey versus cash flow and earnings models.

🏭 Ecolab operates as a major provider of water, hygiene, and infection prevention solutions in the United States and internationally.

πŸ“ˆ Analyst estimates project intermediate Free Cash Flow growth to $1.87 billion in 2026 and $2.40 billion in 2027.

πŸ—£οΈ The analysis suggests investors should weigh bullish narratives around pricing power against risks like softer demand and integration challenges.

Bullish Signals
  • Ecolab is a major player in the water, hygiene, and infection prevention sectors with a strong focus on operational efficiency and resource management.
  • The company has demonstrated consistent long-term growth with a 57.4% return over three years and a 41.8% return over five years.
Risk Factors
  • Valuation models indicate the stock is trading at a significant premium, with a DCF analysis suggesting it is overvalued by approximately 33.1%.
  • The current P/E ratio of 36.93x is substantially higher than the peer group average of 23.26x and the proprietary fair ratio estimate of 24.70x.
  • Analyst forecasts for Free Cash Flow growth are moderate, with projections of $1.87 billion in 2026 and $2.40 billion in 2027.
Full Analysis
Ecolab (ECL) stock recently closed at US$276.29, reflecting gains of 2.7% over the past week and 9.1% over the last month. The article analyzes whether these recent price movements offer genuine value by comparing current market levels against fundamental valuation models, specifically highlighting a significant premium to intrinsic value estimates. Using a two-stage Free Cash Flow to Equity (DCF) model, Simply Wall St calculates an estimated intrinsic value of approximately US$207.51 per share. This implies the stock is trading at a premium of roughly 33.1% above its calculated fair value based on projected future cash flows, which are expected to grow from $2.0 billion in the latest twelve months to $2.47 billion by 2028. The analysis further examines the Price-to-Earnings (P/E) ratio, noting Ecolab trades at 36.93x earnings compared to a peer group average of 23.26x and a proprietary 'Fair Ratio' estimate of 24.70x. While the company provides water, hygiene, and infection prevention solutions, the valuation metrics suggest the stock is priced above fair value relative to both industry peers and specific fundamental models. The article concludes that while Ecolab remains a major player in operational efficiency and resource management, current pricing appears stretched versus cash flow and earnings models. It suggests investors should consider alternative narratives regarding future revenue, margins, and risks like tariffs or demand softness before assuming the high valuation is justified.